Analyst Coverage
| Firm |
Analyst |
| Barclays Capital |
Jim Birchenough, MD |
| Cantor Fitzgerald |
George B. Zavoico, PhD |
| Citigroup |
Yaron Werber, MD |
| Cowen & Co. |
Eric Schmidt, PhD |
| Leerink Swann & Company |
Joseph P. Schwartz |
| Merrill Lynch |
Thomas Chiu |
| Morgan Stanley |
Steven Harr, MD |
| Needham |
Mark Monane, MD |
| Oppenheimer |
Bret Holley, PhD |
| Piper Jaffray |
Thomas Wei |
CV Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CV Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of CV Therapeutics or its management. CV Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.
